News
Virovek Now Delivers AAVs in HEK293 Cells
Hayward, California - March 10, 2021 Virovek is pleased to launch a new service line, producing adeno-associated virus (AAV) vector in human embryonic kidney HEK293 cells through three plasmid transfection method. See our HEK293 page for more details and inventory...
Bio-manufacturing and processing summit (ManuBio USA 2013)
Boston, Massachusetts, June 10-11, 2013 — Virovek was invited to present and showcase its large-scale AAV vector manufacturing process at this inaugural bio-manufacturing and processing…
Discontinuation of Baculovirus Titration Kit, BacEZ Titer Kit
Hayward, California, June 3, 2013 — Virovek announced today it has discontinued its baculovirus titration kit, BacEZ Titer Kit, but will still provide technical support to customers who have previously purchased this product.
Virovek’s latest suicide gene therapy technology
Nanjing, China, April 25-27, 2013 — Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day...
Newest patented technology to manufacture AAV vectors harboring toxins
San Francisco, California, January 7-9, 2013 — Virovek presented its newest patented technology to manufacture AAV vectors harboring toxins, the first of its kind, at the Biotech Showcase 2013 where private and small- and mid-cap…
Avalanche Biotechnologies, Inc. and Lonza will use Virovek’s patented technology
San Francisco, California, and Houston, TX, May 16, 2012 — Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy studies.
Methods in Molecular Biology 737 — Viral Vector for Gene Therapy
Hayward, California, June 10, 2011 — Virovek announced that a new book “Methods in Molecular Biology 737 — Viral Vector for Gene Therapy” has been published by Humana Press (Editors: Otto-Wilhelm Merten & Mohamed Al-Rubeai), in which Dr. Haifeng Chen…
Virovek will cut cost for academic and non-profit organizations
Hayward, California, November 20, 2009 — Virovek announced today that starting on January 1, 2010, Virovek will provide up to 50% discount in fees of AAV vector production services for academic and non-profit organizations…
Virovek launched a new product, BacEZ Titer Kit
Hayward, California, April 10, 2009 — Virovek announced today that it launched a new product, BacEZ Titer Kit, for baculovirus titration. This kit offers customer more reagents for lower cost as compared with other competitors’ similar product. It uses a standard...
Artificial Intron: A New Tool to express Overlapping Genes
San Diego, California, January 12, 2009 — Company CEO, Dr. Haifeng Chen, gave a presentation today at the PepTalk 2009 Conference (January 11 – 16, 2009, San Diego, CA) entitled “The Artificial Intron: A New Tool to express Overlapping Genes in Insect Cells…
MIT will use Virovek’s AAV production technology
Hayward, California, January 7, 2009 — Virovek announced that it signed a licensing agreement with Massachusetts Institute of Technology (MIT) in which MIT will use Virovek’s AAV production technology for its neuroscience research in the viral core facility newly...
Intron splicing-mediated expression of AAV Rep and Cap genes
Hayward, California, February 6, 2008 — Virovek announced today that its manuscript entitled “Intron splicing-mediated expression of AAV Rep and Cap genes and production of AAV vectors in insect cells” has been…
Virovek launched a free AAV vector production program
Hayward, California, October 4, 2007 — Virovek launched a free AAV vector production program today to serve the biotechnology and biopharmaceutical research communities. Because of its robustness of the novel AAV production technology, Virovek is able to cut cost on...